Diacylglycerol kinase zeta inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus.
Diacylglycerol kinase zeta inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus.
复制标题
DOI:
10.1186/1475-2840-7-2
复制
发表时间:
2008-02-04
影响因子:
9.3
通讯作者:
Kubota, Isao
中科院分区:
文献类型:
--
作者:
Bilim, Olga;Takeishi, Yasuchika;Kitahara, Tatsuro;Arimoto, Takanori;Niizeki, Takeshi;Sasaki, Toshiki;Goto, Kaoru;Kubota, Isao
Activation of the diacylglycerol (DAG)-protein kinase C (PKC) pathway has been implicated in the pathogenesis of a number of diabetic complications. Diacylglycerol kinase (DGK) converts DAG to phosphatidic acid and acts as an endogenous regulator of PKC activity. Akt/PKB is associated with a downstream insulin signaling, and PKCβ attenuates insulin-stimulated Akt phosphorylation. We examined transgenic mice with cardiac-specific overexpression of DGKζ (DGKζ-TG) compared to wild type (WT) mice in streptozotocin-induced (STZ, 150 mg/kg) diabetic and nondiabetic conditions. After 8 weeks, decreases in heart weight and heart weight/body weight ratio in diabetic WT mice were inhibited in DGKζ-TG mice. Echocardiography at 8 weeks after STZ-injection demonstrated that decreases in left ventricular end-diastolic diameter and fractional shortening observed in WT mice were attenuated in DGKζ-TG mice. Thinning of the interventricular septum and the posterior wall in diabetic WT hearts were blocked in DGKζ-TG mice. Reduction of transverse diameter of cardiomyocytes isolated from the left ventricle in diabetic WT mice was attenuated in DGKζ-TG mice. Cardiac fibrosis was much less in diabetic DGKζ-TG than in diabetic WT mice. Western blots showed translocation of PKCβ and δ isoforms to membrane fraction and decreased Akt/PKB phosphorylation in diabetic WT mouse hearts. However in diabetic DGKζ-TG mice, neither translocation of PKC nor changes Akt/PKB phosphorylation was observed. DGKζ modulates intracellular signaling and improves the course of diabetic cardiomyopathy. These data may suggest that DGKζ is a new therapeutic target to prevent or reverse diabetic cardiomyopathy.
登录
查看更多内容
影响因子:
13.7
作者:
Abraham, Prema;Adelman, Ron A.;Zhi, Xin (Eric)
通讯作者:
Zhi, Xin (Eric)
DOI:
10.1152/ajpheart.00927.2006
发表时间:
2007-02-01
影响因子:
4.8
作者:
Niizeki, Takeshi;Takeishi, Yasuchika;Kubota, Isao
通讯作者:
Kubota, Isao
影响因子:
4.3
作者:
Rodrigues, B;Cam, MC;McNeill, JH
通讯作者:
McNeill, JH
影响因子:
7.7
作者:
Arikawa, Emi;Ma, Ronald C. W.;King, George L.
通讯作者:
King, George L.
影响因子:
37.8
作者:
Nozaki, N;Shishido, T;Kubota, I
通讯作者:
Kubota, I